Efforts to advance the development of complex generic drugs
The FDA has issued a statement to promote the development of complex generic drugs to ensure access for patients and healthy drug competition The FDA has released a statement highlighting practices to improve the development of complex generic drugs in order to promote drug competition and patient access. The FDA Commissioner Scott Gottlieb wrote: […]
